ArticleThe Journal of infectious diseases2025
Association of a Novel IgG3 Allele With Malaria in Children From the Sepik Region of Papua New Guinea.
Article in The Journal of infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSusceptibility to malaria can be influenced by host genetic factors, including immune response genes. Antibodies against Plasmodium antigens are known to play an important role in protection from clinical disease. Polymorphisms in these antibodies may result in different functional properties that could provide protection from malaria.
methodsImmunoglobulin G1 (IgG1) and immunoglobulin G3 (IgG3) alleles and IgG3 hinge region were investigated by polymerase chain reaction and Sanger sequencing in a longitudinal cohort of children aged 1-3 years (N = 203) from the East Sepik region of Papua New Guinea. Linear regression was used to investigate associations between immunoglobulin alleles and Plasmodium infections.
resultsSeventy-eight percent of the children were either heterozygous (n = 82 [40%]) or homozygous (n = 77 [38%]) for IGHG3*30 (G3m29), a novel IgG3 allele. G3m29 has a long hinge region of 4 exons. Significantly fewer Plasmodium spp infections were observed in children with the IGHG3*30 allele compared to children without the allele (β = -1.736 [95% confidence interval {CI}, -3.39, -.079]; P = .038). This effect was most noticeable for Plasmodium vivax asymptomatic infections as IGHG3*30 carriers had on average 1 fewer infection in the 18-month follow-up period compared with non-IGHG3*30 allele carriers (β = -1.06 [95% CI, -2.01, -.12]; P = .028). Additionally, IGHG3*30 allele carriers had significantly lower levels of IgG to P vivax vaccine candidate proteins compared to non-IGHG3*30 allele carriers.
conclusionsThe IGHG3*30 allele is highly prevalent in the East Sepik region and is associated with fewer Plasmodium spp infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.